Last updated on May 2010

S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer


Brief description of study

The primary goal of this phase II trial is to evaluate the response rate of combination chemotherapy with S-1 and Irinotecan in patients with advanced gastric cancer as a first-line therapy.

Clinical Study Identifier: NCT00343668

Find a site near you

Start Over